GDF15 and mitochondrial disease: Regardless, recent treatment advances specifically in mitochondrial diseases have shown promise in concurrently lowering GDF15 levels and mediating systemic damage, suggesting that GDF15 antagonism may provide benefit in some aspect of systemic mitochondrial disease.